Single, Immediate Postoperative Instillation of Chemotherapy in Non-muscle Invasive Bladder Cancer: a Systematic Review and Network Meta-analysis of Randomized Clinical Trials Using Different Drugs

Overview

Journal Oncotarget

Specialty Oncology

Date 2016 Jun 22

PMID 27323781

Citations 14

Authors

Minyong Kang

Chang Wook Jeong

Cheol Kwak

Hyeon Hoe Kim

Ja Hyeon Ku

Affiliations

Soon will be listed here.

Abstract

We performed a network meta-analysis of randomized controlled trials (RCTs) to compare the efficacy of several intravesical chemotherapeutic (IVC) agents after transurethral resection of bladder tumor (TURB) in non-muscle invasive bladder cancer patients. The literature search was conducted using the Embase, Scopus and PubMed databases for RCTs, including patients with single or multiple, primary or recurrent stage Ta or T1 urothelial carcinoma of the bladder managed with a single, immediate instillation of IVC after TURB. Thirteen RCTs met the eligibility criteria. Pair-wise meta-analysis (direct comparison) showed that pirarubicin [hazard ratio (HR): 0.31], epirubicin (HR: 0.62), and MMC (HR: 0.40) were the most effective drugs for reducing tumor recurrence. Bayesian network meta-analysis (indirect comparison) revealed that treatment with pirarubicin (HR: 0.31), MMC (HR: 0.44), or epirubicin (HR: 0.60) was associated with prolonged recurrence-free survival. Among the drugs examined, only pirarubicin reduced disease progression compared to controls. These results suggest that a single, immediate administration of IVC with pirarubicin, MMC, or epirubicin is associated with prolonged recurrence-free survival following TURB in non-muscle invasive bladder cancer patients, though only pirarubicin also reduced disease progression.

Citing Articles

Clinical value of combining epirubicin with mindfulness intervention in patients with urinary system tumors and depression.

Liu J, Guo Y, Lu Y, Wang B World J Psychiatry. 2025; 15(1):98737.

PMID: 39831015 PMC: 11684209. DOI: 10.5498/wjp.v15.i1.98737.

Low Risk of Severe Complications After a Single, Post-Operative Instillation of Intravesical Chemotherapy in Patients with TaG1G2 Urothelial Bladder Carcinoma.

van Hoogstraten L, Witjes J, Ripping T, Nooter R, Kiemeney L, Aben K Bladder Cancer. 2024; 7(2):193-203.

PMID: 38994541 PMC: 11181802. DOI: 10.3233/BLC-201515.

Single instillation intravesical chemotherapy after radical nephroureterectomy for upper tract urothelial carcinoma: current evidence and future directions.

Refugia J, Tsivian M Transl Androl Urol. 2023; 12(11):1753-1760.

PMID: 38106679 PMC: 10719762. DOI: 10.21037/tau-23-236.

Combined use of a 980‑nm diode laser and preoperative intravesical instillation of pirarubicin for the prevention of short‑term recurrence of non‑muscle invasive bladder cancer: A pilot study.

Tang Z, Peng J, Wu S, Zhao F, Wu M Oncol Lett. 2023; 26(2):322.

PMID: 37415632 PMC: 10320430. DOI: 10.3892/ol.2023.13908.

The prognosis and safety of continuous saline bladder irrigation in patients after transurethral resection of bladder tumors: a systematic review and meta-analysis of comparative study.

Wang X, Wang Y, Che X, Zhou Z, Cheng B Updates Surg. 2023; 75(7):1795-1806.

PMID: 37188906 DOI: 10.1007/s13304-023-01525-4.

References

Dias S, Welton N, Caldwell D, Ades A . Checking consistency in mixed treatment comparison meta-analysis. Stat Med. 2010; 29(7-8):932-44. DOI: 10.1002/sim.3767. View

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

Chamie K, Saigal C, Lai J, Hanley J, Setodji C, Konety B . Compliance with guidelines for patients with bladder cancer: variation in the delivery of care. Cancer. 2011; 117(23):5392-401. PMC: 3206145. DOI: 10.1002/cncr.26198. View

Bohle A, Leyh H, Frei C, Kuhn M, Tschada R, Pottek T . Single postoperative instillation of gemcitabine in patients with non-muscle-invasive transitional cell carcinoma of the bladder: a randomised, double-blind, placebo-controlled phase III multicentre study. Eur Urol. 2009; 56(3):495-503. DOI: 10.1016/j.eururo.2009.06.010. View

Sylvester R, Oosterlinck W, Holmang S, Sydes M, Birtle A, Gudjonsson S . Systematic Review and Individual Patient Data Meta-analysis of Randomized Trials Comparing a Single Immediate Instillation of Chemotherapy After Transurethral Resection with Transurethral Resection Alone in Patients with Stage pTa-pT1 Urothelial.... Eur Urol. 2015; 69(2):231-44. DOI: 10.1016/j.eururo.2015.05.050. View

Ali-El-Dein B, Nabeeh A, El-Baz M, Shamaa S, Ashamallah A . Single-dose versus multiple instillations of epirubicin as prophylaxis for recurrence after transurethral resection of pTa and pT1 transitional-cell bladder tumours: a prospective, randomized controlled study. Br J Urol. 1997; 79(5):731-5. DOI: 10.1046/j.1464-410x.1997.00142.x. View

Parmar M, Torri V, Stewart L . Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med. 1999; 17(24):2815-34. DOI: 10.1002/(sici)1097-0258(19981230)17:24<2815::aid-sim110>3.0.co;2-8. View

Caldwell D, Ades A, Higgins J . Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ. 2005; 331(7521):897-900. PMC: 1255806. DOI: 10.1136/bmj.331.7521.897. View

El-Ghobashy S, El-Leithy T, Roshdy M, El-Ganzoury H . Effectiveness of a single immediate mitomycin C instillation in patients with low risk superficial bladder cancer: short and long-term follow-up. J Egypt Natl Canc Inst. 2008; 19(2):121-6. View

10.

Woods B, Hawkins N, Scott D . Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: a tutorial. BMC Med Res Methodol. 2010; 10:54. PMC: 2906500. DOI: 10.1186/1471-2288-10-54. View

11.

DerSimonian R, Laird N . Meta-analysis in clinical trials. Control Clin Trials. 1986; 7(3):177-88. DOI: 10.1016/0197-2456(86)90046-2. View

12.

Babjuk M, Burger M, Zigeuner R, Shariat S, van Rhijn B, Comperat E . EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol. 2013; 64(4):639-53. DOI: 10.1016/j.eururo.2013.06.003. View

13.

Shelley M, Jones G, Cleves A, Wilt T, Mason M, Kynaston H . Intravesical gemcitabine therapy for non-muscle invasive bladder cancer (NMIBC): a systematic review. BJU Int. 2012; 109(4):496-505. DOI: 10.1111/j.1464-410X.2011.10880.x. View

14.

. The effect of intravesical thiotepa on tumour recurrence after endoscopic treatment of newly diagnosed superficial bladder cancer. A further report with long-term follow-up of a Medical Research Council randomized trial. Medical Research Council.... Br J Urol. 1994; 73(6):632-8. DOI: 10.1111/j.1464-410x.1994.tb07547.x. View

15.

Moher D, Liberati A, Tetzlaff J, Altman D . Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009; 339:b2535. PMC: 2714657. DOI: 10.1136/bmj.b2535. View

16.

Sylvester R, Oosterlinck W, van der Meijden A . A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials. J Urol. 2004; 171(6 Pt 1):2186-90, quiz 2435. DOI: 10.1097/01.ju.0000125486.92260.b2. View

17.

Koya M, Simon M, Soloway M . Complications of intravesical therapy for urothelial cancer of the bladder. J Urol. 2006; 175(6):2004-10. DOI: 10.1016/S0022-5347(06)00264-3. View

18.

Stettler C, Wandel S, Allemann S, Kastrati A, Morice M, Schomig A . Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis. Lancet. 2007; 370(9591):937-48. DOI: 10.1016/S0140-6736(07)61444-5. View

19.

Craig Hall M, Chang S, Dalbagni G, Pruthi R, Seigne J, Skinner E . Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol. 2007; 178(6):2314-30. DOI: 10.1016/j.juro.2007.09.003. View

20.

Tolley D, Parmar M, Lallemand G, Benyon L, Fellows J, Freedman L . The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up. J Urol. 1996; 155(4):1233-8. View